STAT

OCTOBER 30, 2024

H5N1 bird flu virus has been found in a pig on a farm in Oregon, the first time the virus has been seen in a pig in the United States, the U.S. Department of Agriculture reported Wednesday. The pig, one of five on the farm, did not display signs of illness. Two others tested negative and testing is ongoing on the other two. All five were euthanized to allow for study of whether the animals were truly infected.

364

364

PharmaVoice

OCTOBER 30, 2024

Roche recently joined naysayers who argue the deal threatens competition in the burgeoning weight loss and diabetes drug market.

Diabetes 205

Diabetes 205

STAT

OCTOBER 30, 2024

AstraZeneca disclosed Wednesday that Leon Wang , a high-ranking executive who oversees international operations and is also president of its subsidiary in China, is under investigation by Chinese authorities. The company added that it will cooperate, if asked to do so. The move comes after authorities recently detained Eva Yin, a former AstraZeneca executive who is currently chief commercial office for Beigene, a Chinese drugmaker, according to local media reports.

352

352

ALiEM - Pharm Pearls

OCTOBER 30, 2024

‘Dope’ is no longer heroin in an increasing number of our communities. The biggest change has been the gradual replacement of diacetylmorphine (heroin) by fentanyl and other synthetic opioids. Due in large part to the proliferation of anonymous chemical factories able to produce industrial volumes of inexpensive synthetic opioids without opium or other controlled precursors, fentanyl spilled into the United States, Canada, and Europe, heroin soon fell to market forces [1, 2].

HIV Treatment and Prevention Agents 152

HIV Treatment and Prevention Agents Inpatient Hospitals Diabetes 152

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

OCTOBER 30, 2024

All doses of Novo Nordisk’s blockbuster diabetes and obesity treatments are listed as available on the Food and Drug Administration’s drug shortage list as of Wednesday, raising the possibility that the medications could soon be taken off the list entirely, a development that could affect compounding pharmacies and patients relying on compounded drugs.

Compounding Pharmacies 347

Compounding Pharmacies Compounding Diabetes 347

pharmaphorum

OCTOBER 30, 2024

Eli Lilly says a new starting dose regimen for its Alzheimer's disease therapy Kisunla reduces the risk of side effects that have stood in the way of approvals and reimbursement decisions for drugs in its class.Simply shifting one vial of the anti-amyloid antibody from the first infusion to the third infusion of the titration phase of dosing – the period used to achieve therapeutic levels in the body – is enough to lower the incidence of a potentially serious side effect known as ARIA-E, accordi

111

111

pharmaphorum

OCTOBER 30, 2024

Novartis says FDA approval for frontline use of its leukaemia drug Scemblix will boost the number of eligible patients four-fold, as it hunts blockbuster sales

115

115

STAT

OCTOBER 30, 2024

Race and ethnicity are applied in inappropriate and even harmful ways in biomedical research, the National Academies of Science, Engineering, and Medicine said in a report issued Wednesday , calling on scientists, research funders, and publishers to transform the way they use — and don’t use — the categories in research. “The current use of race and ethnicity in research is sometimes seen as an exercise in checking boxes or a matter of using the ‘right’

Labelling 345

Labelling 345

BioPharma Dive

OCTOBER 30, 2024

All doses of the two drugs are now listed as available in the U.S., per an FDA database, although the company cautioned patients may still experience "variability" filling their prescriptions.

107

107

STAT

OCTOBER 30, 2024

Eli Lilly’s third-quarter sales and earnings were lower than expected, a rare stumble for the company that had consistently reported strong sales and beat earnings forecasts since demand for its blockbuster weight loss and diabetes drugs began booming. The company reported Wednesday overall revenue of $11.4 billion, lower than the $12.2 billion expected from analysts polled by Visible Alpha.

Diabetes 300

Diabetes 300

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

The Pharmacist

OCTOBER 30, 2024

National living wage and employer national insurance contributions will increase from April 2025, the chancellor has announced in today's Autumn Budget. But pharmacy leaders have expressed concern that pharmacies will not be able to meet these 'looming increases' unless pharmacy funding is uplifted in the next contract. Increases to living wage and national insurance contributions […] The post National living wage increase will be 'huge additional cost' for pharmacies appeared fi

104

104

STAT

OCTOBER 30, 2024

This close to Nov. 5, we are being battered with promises that this race will determine the future of the country. But Christine Dehlendorf wants people to remember that as important as Election Day is, it won’t be the end of discussions about reproductive health. “No matter what happens next Tuesday … our friends, our families, our children, [and] next generations to come are going to have to be struggling with whether or not they have the right to make decisions about thei

300

300

Med Ed 101

OCTOBER 30, 2024

Dementia with Lewy Bodies (DLB) is a type of dementia grouped under the term “Lewy Body Dementia” along with Parkinson Disease with Dementia (PDD)1. The main symptoms of DLB are parkinsonism, REM sleep disorder, visual hallucinations, and changes in cognition2. There are currently no FDA-approved treatments for DLB. However, rivastigmine, an acetylcholinesterase inhibitor, is FDA-approved […] The post Dementia With Lewy Bodies Treatment appeared first on Med Ed 101.

105

105

STAT

OCTOBER 30, 2024

The STAT Diversity and Inclusion Committee presents STAT’s 2024 Diversity and Inclusion Report. Here, we share the self-reported gender and racial/ethnic demographics of our staff from STAT’s inception in 2015 through 2023, as well as our 2023 new hire demographics.  STAT’s Inaugural Diversity and Inclusion Report, published last year, is available here.

288

288

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

BioPharma Dive

OCTOBER 30, 2024

The British pharma’s experience during the third quarter mirrored that of rival Pfizer, which also reported lower sales of its competing RSV shot.

Vaccines 110

Vaccines 110

STAT

OCTOBER 30, 2024

LONDON — GSK’s once booming vaccines business met new challenges in the third quarter, as the company lowered sales forecasts for vaccines for the year.  Notably, quarterly sales of the company’s RSV vaccine, which became a blockbuster after debuting last year, fell by more than 70% year over year, in part due to narrower U.S. recommendations for who should get the shot.

Vaccines 286

Vaccines 286

Pharmafile

OCTOBER 30, 2024

Sumagen Canada Inc, a biotech company based in both South Korea and Canada has partnered with CDMO Naobios to industrialise Sumagen’s human immunodeficiency virus (HIV) -1 vaccine candidate (SAV0001) at bench scale. First of its kind in human vaccine trials, SAV001 is a whole-killed and genetically modified HIV vaccine. During phase 1 of the clinical […] The post HIV vaccine candidate successfully optimised for industrial production appeared first on Pharmafile.

Vaccines 100

Vaccines 100

STAT

OCTOBER 30, 2024

Health tech investments are showing signs of resilience following the perilous lows of 2022 and 2023: Just this past month, two startups that analysts believe might be getting ready for IPOs raised more than $100 million in late-stage funding rounds. And deal volume hit a record high in the second quarter, largely from early-stage deals, according to a Silicon Valley Bank analysis.

Diabetes 273

Diabetes 273

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

pharmaphorum

OCTOBER 30, 2024

Discover how leveraging AI can help biopharma companies future-proof their operations and strategies. Learn about innovative AI strategies that can drive success in the biopharma industry.

96

96

STAT

OCTOBER 30, 2024

This story first appeared in The Readout newsletter.  Sign up for The Readout  and receive STAT’s award-winning biotech news delivered straight to your inbox.  Good morning. It’s a very busy and spooky Halloween eve today — several companies had big misses in earnings reported this morning. Let’s get into it.

Vaccines 263

Vaccines Drug Pricing Drug Development 263

BioPharma Dive

OCTOBER 30, 2024

Archon Biosciences, co-founded by the winner of the 2024 Nobel Prize in Chemistry, emerged from stealth Wednesday with $20 million in seed capital.

106

106

STAT

OCTOBER 30, 2024

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far, so we are determined to hang on for another couple of days. And why not? The alternatives — at least those we can identify — are not so appealing. And what better way to make the time fly than to keep busy.

Diabetes 256

Diabetes Vaccines 256

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

OCTOBER 30, 2024

The recent FDA decision on the use of MDMA for PTSD treatment has created uncertainty about the future of psychedelic therapy. Learn more about the implications and potential impact on patients.

88

88

STAT

OCTOBER 30, 2024

Axonis Therapeutics, a biotech company that has been quietly operating for the last five years, has raised $115 million after retooling its drug pipeline.  The startup announced Wednesday that it closed a Series A round led by Cormorant Asset Management and venBio Partners — its first major financing after subsisting on a string of seed financing deals.

Drug Development 241

Drug Development 241

pharmaphorum

OCTOBER 30, 2024

The UK's first female Chancellor Rachel Reeves pumps billions into NHS in the first Labour budget in 14 years

110

110

STAT

OCTOBER 30, 2024

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Hello! Long-time listener, first-time caller. This is Anil Oza, STAT’s Sharon Begley reporting fellow this year. I cover everything from see-through mice to why Bill Nye has rebranded as an activist this year.

226

226

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

PharmaVoice

OCTOBER 30, 2024

Leaders molding the cutting-edge cell and gene therapy field into tomorrow's cures.

130

130

STAT

OCTOBER 30, 2024

Semaglutide, better known as Ozempic and Wegovy, helped alleviate pain from knee osteoarthritis and improve function in patients with severe obesity, a new study found.  The results of the 68-week trial were published in the New England Journal of Medicine , and could pave the way for a future FDA approval of GLP-1 receptor agonists for the joint-degrading condition.

245

245

The Pharmacist

OCTOBER 30, 2024

The first confirmed human case of Clade Ib mpox in the UK has been detected in London, the UK Health Security Agency (UKHSA) has said. But it stressed that the risk to the UK population 'remains low'. And Steve Russell, NHS national director for vaccination and screening, said there were 'plans in place to expand […] The post First UK case of Clade IB mpox could prompt ‘quick vaccine expansion’ appeared first on The Pharmacist.

Vaccines 79

Vaccines 79

Express Pharma

OCTOBER 30, 2024

Biocon and Dr Reddy’s Laboratories have been named in the 2024 Top Biotech and Pharma Employers Survey by Science Magazine, Securing the No. 9 and No. 15 spot respectively. Biocon’s ranking includes both Biocon and its subsidiary Biocon Biologics, as employees from both organisations participated in the survey. Biocon has consistently been featured, since debuting in the list in 2012.

Pharmaceutical Companies 79

Pharmaceutical Companies Pharmaceutical Companies 79

BioPharma Dive

OCTOBER 30, 2024

The funding for Axonis, which is developing novel medicines for pain and epilepsy, reflects growing confidence in precision therapies for neurological diseases, one investor told BioPharma Dive.

70

70